We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01318174
First Posted: March 18, 2011
Last Update Posted: July 8, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Aleksander Talgøy Holten, Sykehuset Innlandet HF
March 17, 2011
March 18, 2011
July 8, 2014
April 2011
April 2012   (Final data collection date for primary outcome measure)
Prevalence of pulmonary embolism in exacerbations of COPD [ Time Frame: one year ]
Not Provided
Complete list of historical versions of study NCT01318174 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease
Prevalence of Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease
The purpose of this study is to determine the prevalence of pulmonary embolism in our population of Chronic Obstructive Pulmonary Disease (COPD) patients admitted to hospital with dyspnea. The patients will undergo investigation for pulmonary embolism, according to current guidelines.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients with known or suspected COPD admitted with an exacerbation of unknown aetiology
  • Pulmonary Embolism
  • Chronic Obstructive Pulmonary Disease
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
38
April 2013
April 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • known or suspected COPD
  • COPD-exacerbation

Exclusion Criteria:

  • other causes of dyspnea
  • unable to perform CT pulmonary angio (contrast allergy, pregnancy)
  • already included in the study (each patient included only once)
  • use of anticoagulants
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
 
NCT01318174
LE-KE
No
Not Provided
Not Provided
Aleksander Talgøy Holten, Sykehuset Innlandet HF
Sykehuset Innlandet HF
Not Provided
Principal Investigator: Aleksander T Holten, PhD Sykehuset Innlandet HF
Sykehuset Innlandet HF
July 2014